Cover Page

Cite item


Introduction. Therapeutic dental manipulations in smaller children are usually done under general anesthesia and sedation using inhalation anesthetics due to their high psychoemotional lability. Xenon (inert gas) is of particular interest among inhalation anesthetic agents due to its unique pharmacological properties such as hypnotic and analgesic effect, lack of toxicity, organ protective properties, etc. Purpose is to estimate adequacy, safety and comfort with anesthesia in pediatric dentistry. Materials and methods. 30 children (18 boys and 12 girls) were involved in an open, prospective, randomized study. They obtained dental treatment for caries and pulpitis. Sevoflurane 8% and concentration of 60–70% xenon with О2 was given to induce anesthesia. Anesthesia adequacy, safety and comfort were estimated based on hemodynamics data, BIS index, concentrations of sevoflurane and xenon in the anesthetic gas, recovery time, rate of agitation, nausea and vomiting. Results. The study demonstrated safety of xenon gas anesthesia in pediatric dentistry. The estimated values were within the reference range. Following anesthesia, recovery occurred after 30 minutes, no single case of postanesthesia agitation, nausea and vomiting was noted. Conclusion. Xenon provides for high effectiveness and safety of anesthesia in pediatric dentistry. The results show that further studies are reasonable.

About the authors

V. V. Lazarev

“Pirogov Russian National Research Medical University”, Moscow

Author for correspondence.
Email: lazarev_vv@inbox.ru
Dr. Sci (Med), Professor, head of Department of pediatric anesthesiology and intensive therapy Russian Federation

D. M. Khaliullin

LLC “Dental Forte Elit”: Russian Federation; Naberezhnye Chelny, Naberezhnochelninsky Avenue 10B, Republic of Tatarstan

Email: dr170489@yandex.ru
Anesthesiologist resuscitator Russian Federation

R. R. Gabdrafikov

LLC “Dental Forte Elit”: Russian Federation; Naberezhnye Chelny, Naberezhnochelninsky Avenue 10B, Republic of Tatarstan

Email: gendirector@dental-forte.ru
Dentist, chief physician of dental Forte Elite Russian Federation

D. V. Koshcheev

LLC “Dental Forte Elit”: Russian Federation; Naberezhnye Chelny, Naberezhnochelninsky Avenue 10B, Republic of Tatarstan

Email: dvkoshceev@gmail.com
Anesthesiologist resuscitator Russian Federation

E. S. Gracheva

LLC “Dental Forte Elit”: Russian Federation; Naberezhnye Chelny, Naberezhnochelninsky Avenue 10B, Republic of Tatarstan

Email: murzic_elen@icloud.com
Dentist Russian Federation


  1. Magno M. B., de Paiva Cabral Tristão S. K., Jural L. A., Aguiar Sales Lima S. O., Coqueiro R. D.S., Maia L. C., Pithon M. M. Does dental trauma influence the social judgment and motivation to seek dental treatment by children and adolescents? Development, validation, and application of an instrument for the evaluation of traumatic dental injuries and their consequences. Int. J. Paediatr. Dent. 2019; Feb 8. doi: 10.1111/ipd.12479.
  2. Campbell R. L., Shetty N. S., Shetty K. S., Pope H. L., Campbell J. R. Pediatric Dental Surgery Under General Anesthesia: Uncooperative Children. Anesth. Prog. 2018; 65(4):225–230, doi: 10.2344/anpr-65–03–04.
  3. Deile M., Damm M., Heller A. R. Inhaled anesthetics. Anaesthesist. 2013;62(6):493–504. doi: 10.1007/s00101–013– 2175–9.
  4. Safari S., Motavaf M., Seyed Siamdoust S. A., Alavian S. M. Hepatotoxicity of halogenated inhalational anesthetics. Iran Red. Crescent. Med. J. 2014;16(9): e20153. doi: 10.5812/ircmj.20153.
  5. Багаев В. Г., Девайкин Е. В., Амчеславский В. Г., Потапов В. Н., Боярский С. Н. Различные виды анестезий с использованием ксенона у детей. Педиатрическая фармакология. 2012;9(1):72–76. doi.org/10.15690/pf.v9i1.167.
  6. Devroe S., Meeusen R., Gewillig M., Cools B., Poesen K., Sanders R., Rex S. Xenon as an adjuvant to sevoflurane anesthesia in children younger than 4 years of age, undergoing interventional or diagnostic cardiac catheterization: A randomized controlled clinical trial. Paediatr. Anaesth. 2017; 27(12):1210–19. DOI:10.1111.
  7. Cremer J., Stoppe C., Fahlenkamp A. V., Schälte G., Rex S., Rossaint R., Coburn M. Earli cognitive fancion, recovery and well-being after sevoflurane and xenon anaesthesia in the elderly: a doubl-blinded randomized controlled trial. Med. Gas. Res. 2011;1(1):1–9. doi: 10.1186/2045–9912–1–9.
  8. Fahlenkamp A. V., Krebber.F, Rex S., Grottke O., Fries M., Rossaint R., Coburn M. Bispectral index monitoring during balanced xenon or sevoflurane anaesthesia in elderly patient. Eur. J. Anaesthesiol. 2010;27(10):906–11. DOI: 10.1097/ EJA.0b013e32833d1289.
  9. Höcker J., Raitschew B., Meybohm P., Broch O., Stapelfeldt C., Gruenewald M., Cavus E., Steinfath M., Bein B. Differences between bispectral index and spectral entropy during xenon anaesthesia: a comparison with propofol anaesthesia. Anaesthesia 2010; 65(6): 595–600. doi.org/10.1111/j.1365–2044.2010.06344.x.
  10. Stuttmann R., Schäfer C., Hilbert P., Meyer M. R., Maurer H. H. The breast feeding mother and xenon anaesthesia: four case reports. Breast feeding and xenon anaesthesia. BMC Anesthesiol. 2010;10:1–18. doi: 10.1186/1471–2253–10–1.
  11. Stoppe C., Peters D., Fahlenkamp A. V., Cremer J., Rex S., Schälte G., Rossaint R., Coburn M. AepEX monitor for the measurement of hypnotic depth in patients undergoing balanced xenon anaesthesia. Br. J. Anaesth. 2012;108(1):80–8. doi: 10.1093/bja/aer393.
  12. Vizcaychipi M. P., Lloyd D. G., Wan Y., Palazzo M. G., Maze M., Ma D. Xenon pretreatment may prevent early memory decline after isoflurane anesthesia and surgery in mice. PLoS One. 2011;6(11): e26394. doi: 10.1371/journal. pone.0026394.
  13. Багаев В. Г., Амчеславский В. Г., Хмельницкий К. Е. Результаты клинического исследования эффективности и безопасности ксенона при общей анестезии у детей. Российский вестник детской хирургии, анестезиологии и реаниматологии. 2012;2(4):70–77.
  14. Китиашвили И. З., Буров Н. Е., Фрейлин И. С., Хрыкова Е. В. Динамика клеточного иммунитета и цитокинов под влиянием анестезии ксеноном и закисью азота. Анестезиология и реаниматология. 2006; (2): 4–9.
  15. Довгуша В. В., Фок М. В., Зарицкая Г. А. Возможный и молекулярный механизм наркотического действия инертных газов. Биофизика. 2005;50(5):903–908.
  16. Китиашвили И. З., Буров Н. Е. Сравнительная оценка гемодинамических, гормональных и метаболических показателей в условиях анестезии ксеноном и закисью азота. Вестник интенсивной терапии. 2006;(1):57–60.
  17. Law L. S., Lo E. A., Gan T. J. Xenon Anesthesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Anesth Analg. 2016;122(3):678–97. doi: 10.1213/ANE.0000000000000914.
  18. Gill H. Xenon-augmented pediatric anesthesia: A small step closer? Paediatr Anaesth. 2017;27(12):1174–5. doi: 10.1111/ pan.13265.
  19. Jin Z., Piazza O., Ma D., Scarpati G., De Robertis E. Xenon anesthesia and beyond: pros and cons. Minerva Anestesiol. 2019;85(1):83–9. doi: 10.23736/S0375–9393.18.12909–9.
  20. Kulikov A., Bilotta F., Borsellino B., Sel’kov D., Kobyakov G., Lubnin A. Xenon anesthesia for awake craniotomy: safety and efficacy. Minerva Anestesiol. 2019 Feb;85(2):148–55. doi: 10.23736/S0375–9393.18.12406–0.
  21. Xia Y., Fang H., Xu J., Jia C., Tao G., Yu B. Clinical efficacy of xenon versus propofol: A systematic review and metaanalysis. Medicine (Baltimore). 2018 May;97(20): e10758. doi: 10.1097/MD.0000000000010758.
  22. Meloni E. G., Gillis T. E., Manoukian J., Kaufman M. J. Xenon impairs reconsolidation of fear memories in a rat model of post-traumatic stress disorder (PTSD). PLoS One. 2014 Aug 27;9(8): e106189. doi: 10.1371/journal.pone.0106189. eCollection 2014.

Copyright (c) 2019 Lazarev V.V., Khaliullin D.M., Gabdrafikov R.R., Koshcheev D.V., Gracheva E.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 81892 от 24.09.2021 г.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies